The six hepatitis B vaccines licensed for use in the United States afford lifelong protection (immunity) if the two- or three-dose series is completed on the recommended schedule. Among those who ...

They are considered protected if they have a hepatitis B surface antigen antibody (anti-HBs) titer of ≥10 mIU/mL after completing a full vaccination series. This study compared the effectiveness ...

Engerix-B (hepatitis B vaccine [recombinant]) is a prescription vaccine that’s used to help prevent hepatitis B. Engerix-B comes as a liquid suspension for intramuscular injection. Engerix-B is ...

They are considered protected if they have a hepatitis B surface antigen antibody (anti-HBs) titer of ≥10 mIU/mL after completing a full vaccination series. This study compared the effectiveness ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of the virus in the body, such as HBV antigens or antibodies. They also ...

Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

Presenters can share, discuss and provide updates on case management recommendations, ACIP-recommended practices for hepatitis B vaccines, and updates from the Perinatal Hepatitis B Prevention ...

Hepatitis B vaccine (recombinant ... born weighing <2,000 g should not be counted as the first dose in the vaccine series; it should be followed with a full 3-dose standard regimen (total of ...